VIRGINIA WOHLTMANN: Open Payments
NPI 1740332915 · FAIRPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,224 in 118 payments from 12 companies in 2025. Trend: 2023 $906 · 2024 $1,602 · 2025 $2,224
Food & beverage: $2,005Education: $218
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 34 | $606 |
| Neurocrine BioSciences, Inc. | 21 | $401 |
| Janssen Pharmaceuticals, Inc | 19 | $401 |
| E.R. Squibb & Sons, L.L.C. | 20 | $340 |
| Alkermes, Inc. | 5 | $118 |
| Supernus Pharmaceuticals, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $84 |
| Corium, LLC | 4 | $50 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
Products named: INGREZZA, INVEGA SUSTENNA, COBENFY, UZEDY, AUSTEDO XR, ARISTADA, Qelbree, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
